packageBexarotene

bexarotene

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Bexarotene is a retinoid anticancer drug used to treat cutaneous T-cell lymphoma, including mycosis fungoides. It is approved and authorised in the European Union for this cancer, and is also being studied for other investigational uses.

Summary written by glm-5.3-flash from Wikidata Q418192 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:bexarotene
ATC codes:L01XF03
DrugBank:DB00307
PubChem CID:82146
ChEBI:50859
Wikidata:Q418192
formula:C24H28O2
molar mass:348.486 g/mol (PubChem CID 82146)
logP:7.6 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown